Guoyao Tang Selected Research

Oral Lichen Planus

1/2021	Elevated mean platelet volume in oral lichen planus and increased blood urea nitrogen level in its red-form: an observational study.
4/2020	Enhanced T-cell proliferation and IL-6 secretion mediated by overexpression of TRIM21 in oral lesions of patients with oral lichen planus.
1/2020	TRIM21 causes abnormal expression of IL-6 in oral lichen planus via the TRIB2-MAPK signal axis.
1/2018	Mixed and inhomogeneous expression profile of Th1/Th2 related cytokines detected by cytometric bead array in the saliva of patients with oral lichen planus.
1/2018	Increased infiltration of CD11 c+/CD123+ dendritic cell subsets and upregulation of TLR/IFN-α signaling participate in pathogenesis of oral lichen planus.
1/2018	Differential expression of STAT-3 in subtypes of oral lichen planus: a preliminary study.
10/2017	Integrative analysis of mRNA and miRNA expression profiles in oral lichen planus: preliminary results.
7/2016	Total glucosides of paeony (TGP) inhibits the production of inflammatory cytokines in oral lichen planus by suppressing the NF-κB signaling pathway.
7/2016	Clinical observation on the treatment of oral lichen planus with total glucosides of paeony capsule combined with corticosteroids.
6/2016	Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guoyao Tang Research Topics

Disease

12	Oral Lichen Planus 01/2021 - 02/2015
3	Ulcer 06/2022 - 01/2022
3	Aphthous Stomatitis (Aphthous Ulcer) 01/2022 - 01/2018
3	Oral Leukoplakia 12/2021 - 03/2020
2	Erythema 06/2022 - 01/2018
2	Carcinogenesis 01/2022 - 01/2018
2	Neoplasms (Cancer) 01/2022 - 03/2020
2	Squamous Cell Carcinoma of Head and Neck 12/2021 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 07/2016
1	Pain (Aches) 01/2022
1	Kidney Diseases (Kidney Disease) 07/2021
1	Periodontitis 01/2021
1	Alveolar Bone Loss 01/2021
1	Keratosis 01/2018
1	Hypoxia (Hypoxemia) 02/2015

Drug/Important Bio-Agent (IBA)

4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 06/2016
3	Proteins (Proteins, Gene)FDA Link 04/2020 - 02/2015
2	Long Noncoding RNAIBA 01/2022 - 10/2021
2	CytokinesIBA 01/2018 - 07/2016
2	Messenger RNA (mRNA)IBA 10/2017 - 02/2015
2	GlucosidesIBA 07/2016 - 07/2016
1	Prostaglandins AIBA 06/2022
1	Thalidomide (Thalomid)FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2021
1	CreatinineIBA 07/2021
1	AlbuminsIBA 07/2021
1	Silk FDA Link 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	NitrogenIBA 01/2021
1	AntigensIBA 01/2021
1	ParaffinIBA 04/2020
1	casticinIBA 03/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	salvianolic acid BIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 10/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2016
1	Capsules (Microcapsules)IBA 07/2016
1	Transcription Factors (Transcription Factor)IBA 06/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 06/2016
1	Interleukin-12 Subunit p35IBA 09/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2015

Therapy/Procedure

2	Photochemotherapy (Photodynamic Therapy) 12/2021 - 03/2020
1	Oral Medicine 01/2022
1	Lasers (Laser) 12/2021
1	Ligation 01/2021
1	Gas Lasers 03/2020